As of 2026-02-09, the Intrinsic Value of Passage Bio Inc (PASG) is -71.17 USD. This PASG valuation is based on the model Peter Lynch Fair Value. With the current market price of 9.51 USD, the upside of Passage Bio Inc is -848.37%.
Based on its market price of 9.51 USD and our intrinsic valuation, Passage Bio Inc (PASG) is overvalued by 848.37%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -71.17 - -71.17 | -71.17 | -848.37% |
| P/E | (164.83) - (278.13) | (247.67) | -2704.3% |
| DDM - Stable | (104.56) - (324.35) | (214.46) | -2355.1% |
| DDM - Multi | (137.56) - (337.67) | (196.14) | -2162.4% |
| Market Cap (mil) | 30.24 |
| Beta | 2.05 |
| Outstanding shares (mil) | 3.18 |
| Enterprise Value (mil) | -22.53 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.74% |
| Cost of Debt | 5.00% |
| WACC | 7.20% |